Vol. 49 | No. 2 | July-December 2021Back

Open Access

Dual Antiplatelet Versus Single Antiplatelet in Post– Transcatheter Aortic Valve Implantation/Transcatheter Aortic Valve Replacement for Stroke Prevention: A Systematic Review and Meta-analysis

More Info

Ralph Yap, MD | Douglas Bailon, MD | Abigail Louise Te-Rosano, MD 

St Luke’s Medical Center—Global City, Taguig 

  1. Thaden JJ, Nkomo VT, Enriquez-Sarano, M. The Global Burden of Aortic Stenosis. Prog Cardiovasc Dis 2014;56(6):565–571. doi:10.1016/j.pcad.2014.02.006
  2. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13(5):704–708. doi:10.1093/oxfordjournals.eurheartj. a060238.
  3. Rajput FA, Zeltser R. Aortic valve replacement [updated March 31, 2019]. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; January 2019. Available at: https://www.ncbi.nlm.nih.gov/books/NBK537136/.
  4. Ferlini M, Mauri S, Rossini R. Dual antiplatelet therapy after TAVR: a drop in the bucket? Int J Cardiol 2019;280:46–48. doi:10.1016/j.ijcard.2019.01.069.
  5. Nijenhuis VJ, Bennaghmouch N, Hassell M, et al. Rationale and design of POPular-TAVI: antiPlatelet therapy for Patients undergoing Transcatheter Aortic Valve Implantation. Am Heart J 2016;173:77–85. doi:10.1016/j. ahj.2015.11.008.
  6. Rodés-Cabau J, Dauerman HL, Cohen MG, et al. Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events. J Am Coll Cardiol 2013;62:2349–2359.
  7. Nombela-Franco L, Webb JG, de Jaegere PP, et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 2012;126:3041–3053.
  8. Van Mieghem NM, Schipper ME, Ladich E, et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation 2013;127:2194–2201.
  9. Rodés-Cabau J, Masson JB, Welsh RC, et al. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve. JACC Cardiovasc Interv 2017(13):1357–1365. doi:10.1016/j.jcin.2017.04.014.
  10. Stabile E, Pucciarelli A, Cota L, et al. SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. Int J Cardiol 2014;174(3):624–627. doi:10.1016/j.ijcard.2014.04.170.
  11. Ussia GP, Scarabelli M, Mulè M, et al. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol, 2011;108(12):1772–1776. doi:10.1016/j. amjcard.2011.07.049.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.